Evidence map›Paper›PMID 41668480›Full record

ArticleClinical pharmacology and therapeutics2026

Representation, Access, and Inclusion in Clinical Trials: A Patient-Centered Perspective from the ASCPT 2025 Patient Forum.

Stephani L Stancil, Ricki Fairley, Latoya Bolds-Johnson, Hope Krebill, Barbara E Bierer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical pharmacology and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Stephani L StancilDepartment of Pediatrics, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.ORCID 0000-0001-7308-3132
Ricki FairleyTouch, The Black Breast Cancer Alliance, Annapolis, Massachusetts, USA.
Latoya Bolds-JohnsonTouch, The Black Breast Cancer Alliance, Annapolis, Massachusetts, USA.ORCID 0009-0003-6769-2400
Hope KrebillMasonic Cancer Alliance, The University of Kansas, Cancer Center, University of Kansas, Medical Center, Kansas City, Kansas, USA.ORCID 0000-0001-9935-1158
Barbara E BiererThe Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard, Boston, Massachusetts, USA.ORCID 0000-0001-6448-8170

Funding

Development of a Pharmacodynamic Biomarker of Opioid Antagonism in Adolescents with Eating DisordersK23MH130728 · NIMH · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI Stephani L Stancil · 2023 to 2026
$740k
NIMH NIH HHS K23 MH130728
6 · The paper itself

Abstract

Clinical trials drive therapeutic innovation but often underrepresent populations most affected by the disease. Despite efforts to include women, minorities, and children, participation still lags behind intent. Ensuring equitable representation is essential to maximize the impact of new therapies. This perspective offers actionable insights from a diverse panel-including patients, clinicians, researchers, and advocates-shared during the 2025 American Society for Clinical Pharmacology and Therapeutics Patient Forum.

Indexed as

Clinical Trials as TopicDiversity, Equity, InclusionFemaleHumansPatient-Centered Care

Identifiers

PMID41668480
PMCPMC13141312

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.